RECURSION PHARMACEUTICALS, INC. (RXRX)

Import this data to Google Sheets with:

=jivedata("RXRX","financials")

Full statements spill as a table. For one cell: =jivedata("RXRX","Revenue") or =jivedata("RXRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

RECURSION PHARMACEUTICALS, INC.

RXRX • CIK 0001601830

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-350,060	$-479,004	$-648,132	$-544,009
Nonoperating Income (Expense)	$17,932	$14,216	$3,237	$20,543
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-332,128	$-464,788	$-644,895	$-523,466
Income Tax Expense (Benefit)	$-4,062	$-1,127	$-136	$-4,582
Net Income (Loss) Attributable to Parent	$-328,066	$-463,661	$-644,759	$-518,884
Revenue from Contract with Customer, Excluding Assessed Tax	$44,575	$58,839	$74,681	$54,856
Cost of Goods and Services Sold	$42,587	$45,238	$70,953	$52,944
Research and Development Expense	$241,226	$314,421	$475,271	$394,512
General and Administrative Expense	$110,822	$178,184	$176,589	$151,409
Costs and Expenses	$394,635	$537,843	$722,813	$598,865
Weighted Average Number of Shares Outstanding, Basic	207,853,702	274,207,146	447,446,109	568,068,663

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$391,565	$594,350	$743,294	$545,683
Restricted Cash, Current	$3,231	$3,045	$4,594	$5,385
Restricted Cash, Noncurrent	$6,629	$5,629	$6,033	$5,752
Other Receivables, Net, Current	$3,094	$49,166	$24,649	$14,393
Property, Plant and Equipment, Net	$86,510	$141,063	$103,931	$89,623
Prepaid Expense, Current	—	—	$11,742	$8,680
Operating Lease, Right-of-Use Asset	$33,663	$65,877	$45,339	$40,271
Other Assets, Current	$40,247	$67,708	$28,566	$29,321
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	—	$26,273	$20,210	$17,179
Assets, Current	$438,137	$714,269	$812,845	$603,462
Intangible Assets, Net (Excluding Goodwill)	$36,443	$335,855	$309,903	$282,888
Goodwill	$52,056	$148,873	$162,158	$160,350
Deferred Income Tax Assets, Net	—	$1,934	$957	$957
Other Assets, Noncurrent	$261	$8,825	$12,754	$12,186
Assets	$653,699	$1,448,598	$1,474,130	$1,212,668
Contract with Customer, Liability, Noncurrent	$51,238	$118,765	$114,012	$112,818
Operating Lease, Liability, Noncurrent	$43,414	$67,250	$46,647	$39,193
Long-term Debt and Lease Obligation	—	$19,022	$9,564	$4,753
Deferred Income Tax Liabilities, Net	$1,339	$16,575	$23,255	$18,313
Other Liabilities, Noncurrent	—	$4,732	$2,080	$2,702
Liabilities	$190,263	$413,816	$343,265	$297,665
Accounts Payable, Current	$3,953	$21,613	$18,118	$12,672
Accrued Liabilities, Current	$46,635	$81,872	$70,230	$56,936
Contract with Customer, Liability, Current	$36,426	$61,767	$37,605	$27,586
Operating Lease, Liability, Current	$6,116	$13,795	$12,663	$13,249
Long-term Debt and Lease Obligation, Current	—	$8,425	$9,091	$9,443
Liabilities, Current	$93,171	$187,472	$147,707	$119,886
Common Stock, Value, Issued	$2	$4	$5	$5
Additional Paid in Capital	$1,431,056	$2,473,698	$3,170,145	$3,211,515
Retained Earnings (Accumulated Deficit)	$-967,622	$-1,431,283	$-2,076,002	$-2,324,511
Accumulated Other Comprehensive Income (Loss), Net of Tax	—	$-7,637	$36,717	$27,994
Stockholders' Equity Attributable to Parent	$463,436	$1,034,782	$1,130,865	$915,003
Common Stock, Shares Authorized	2,000,000,000	2,000,000,000	2,000,000,000	2,000,000,000
Common Stock, Shares, Issued	234,270,384	396,802,394	528,182,693	534,120,235
Finance Lease, Liability, Current	—	$8,311	$8,967	$8,967
Finance Lease, Liability, Noncurrent	—	$18,338	$9,371	$9,371

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$188	$-3,406	$18,044	$937
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-157,687	$201,599	$150,897	$22,975
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$401,425	$603,024	$753,921	$909,944
Net Income (Loss) Attributable to Parent	$-328,066	$-463,661	$-644,759	$-518,884
Net Cash Provided by (Used in) Operating Activities	$-287,780	$-359,174	$-371,808	$-350,481
Payments to Acquire Businesses, Net of Cash Acquired	$-1,844	$-277,104	$0	$0
Payments to Acquire Property, Plant, and Equipment	$11,955	$13,695	$6,469	$1,789
Payments to Acquire Intangible Assets	$597	$3,350	$2,158	$1,995
Proceeds from Divestiture of Businesses, Net of Cash Divested	—	—	$-4,438	$0
Payments to Acquire Investments	—	—	$3,806	$2,306
Proceeds from Sale and Maturity of Marketable Securities	—	$0	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-10,228	$260,059	$-16,871	$-6,090
Proceeds from Issuance of Common Stock	$128,093	$300,417	$528,864	$387,840
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$12,806	$8,143	$4,093	$4,093
Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security	—	$4,440	$8,425	$8,753
Net Cash Provided by (Used in) Financing Activities	$140,133	$304,120	$521,532	$378,609
Stock Issued	$89,269	$630,124	$20,315	$20,315
Capital Expenditures Incurred but Not yet Paid	$2,439	$439	$0	$37
Noncash or Part Noncash Acquisition, Intangible Assets Acquired	—	$6,000	$0	$1,915
Depreciation, Depletion and Amortization	$24,402	$36,494	$83,701	$78,361
Share-based Payment Arrangement, Noncash Expense	$53,503	$81,688	$111,223	$90,719
Tangible Asset Impairment Charges	$1,188	$108	$5,956	$0
Operating Lease, Expense	$8,063	$16,616	$22,249	$20,953
Gain (Loss) on Disposition of Business	—	—	$-4,502	$0
Research and Development Asset Acquired Other than Through Business Combination, Written-off	—	—	$22,082	$22,082
Other Noncash Income (Expense)	$-3,387	$-7,582	$-9,550	$-2,866
Increase (Decrease) in Other Operating Assets	$7,756	$6,071	$-32,939	$-11,147
Increase (Decrease) in Contract with Customer, Liability	$-41,076	$-28,038	$-36,771	$-22,940
Increase (Decrease) in Accounts Payable	$-987	$6,435	$-2,616	$-7,073
Increase (Decrease) in Other Accrued Liabilities	$6,719	$5,519	$-7,407	$-4,817

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("RXRX","financials")

Full statements spill as a table. For one cell: =jivedata("RXRX","Revenue") or =jivedata("RXRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.